Skip to main content

Table 4 Multicategory Global test p value for pathway level associations of tumor expression of the metabolic pathways with histologic and molecular features of prostate cancer

From: The role of tumor metabolism as a driver of prostate cancer progression and lethal disease: results from a nested case-control study

Pathway (n genes)

Ki-67 quartiles (n = 314 men)

Apoptosis quartiles (n = 255 men)

Microvessel density quartilesa(n = 174 men)

Perineural invasiona(n = 132 men)

Fatty acid metabolism (n = 39)

1.8 × 10−4

0.20

0.01

1.1 × 10−6

Glycolysis/gluconeogenesis (n = 62)

9.4 × 10−9

0.19

0.06

1.2 × 10−4

Pentose phosphate (n = 27)

4.0 × 10−6

0.20

0.14

0.04

Purine metabolism (n = 157)

4.1 × 10−6

0.42

0.09

1.9 × 10−5

Pyrimidine metabolism (n = 96)

2.8 × 10−6

0.64

0.17

3.5 × 10−4

Oxidative phosphorylation (n = 123)

3.1 × 10−8

0.09

2.0 × 10−3

0.02

TCA (n = 30)

1.1 × 10−7

0.30

0.04

0.37

  1. All tests compare the null model including only age at diagnosis, cohort (PHS, HPFS) if data was available for both, year of diagnosis, and BMI at diagnosis to the full model which also includes the genes in the listed pathway
  2. aData was only available for HPFS so cohort was excluded from these models